mineral trioxide aggregate: Clinical Trials

51 trials of mineral trioxide aggregate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

31 completed, 13 unknown, 5 not yet recruiting, 1 active not recruiting. 29 Not applicable, 10 Phase 2, 7 Phase 4, 6 Phase 3, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable29Completed 17, Unknown 7, Not yet recruiting 4, Active not recruiting 1
Phase 210Completed 5, Unknown 4, Not yet recruiting 1
Phase 47Completed 5, Recruiting 1, Unknown 1
Phase 36Completed 5, Unknown 1
Phase 14Completed 3, Unknown 1
Early Phase 12Completed 1, Unknown 1

Follow mineral trioxide aggregate: new trials by email Literature Review of mineral trioxide aggregate trials Research Report on mineral trioxide aggregate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Salvadora Persica-Zinc Oxide Versus MTA as Pulpotomy Agents in Mature Permanent Molars With Irreversible Pulpitis
Mineral Trioxide Aggregate, Salvadora persica Extract + Zinc Oxide - Irreversible Pulpitis
Not applicableNot yet recruitingPostgraduate Medical Institute, Lahore782026-06-202026-06-05
Comparative Evaluation of Calcium Silicate-doped Treated Dentin Matrix and Mineral Trioxide Aggregate as Miniature Pulpotomy Biomaterials in Deep Carious Lesions
Calcium Silicate doped treated dentin matrix for miniature pulpotomy (CaSi+hTDM MP)., Mineral Trioxide Aggregate (MTA) for Miniature Pulpotomy - Reversible Pulpitis, Deep Carious Lesions
Not applicableNot yet recruitingAll India Institute of Medical Sciences562026-04-252026-03-10
Total Pulpotomy With Two Repair Cements in Hypomineralized Teeth
MTA group, CIMMO DTA® group - Molar-Incisor Hypomineralization (MIH)
Not applicableActive not recruitingMeire Coelho Ferreira1202026-04-162026-08-20
Comparison of Hyaluronic Acid, TheraCal, and Mineral Trioxide Aggregate as Pulpotomy Agents in Primary Molars
Hyaluronic Acid (HA), TheraCal, Mineral Trioxide Aggregate - Pulpotomies Primary Teeth, Pulp Disease, Dental
Not applicableNot yet recruitingAl-Azhar University662025-10-012025-09-11
Clinical and Radiographic Evaluation of Indirect Pulp Capping Using Platelet Rich Fibrin Versus Mineral Trioxide Aggregate in Deep Carious Molars: a Randomized Controlled Trial
MTA, PRF - Dental Caries, Pulp Caping
Phase 2Not yet recruitingCairo University502025-06-012025-03-21
Outcome of Pulpotomy With MTA and Biodentin in Permanent Teeth With Caries Exposure
Pulp Therapy with Mineral trioxide aggregate (MTA), Pulp Therapy with Biodentine - Pulpitis - Irreversible
Not applicableNot yet recruitingAltamash Institute of Dental Medicine1362025-05-022025-04-24
TheraCal Materials Versus MTA in Full Pulpotomy
Mineral Trioxide Aggregate (MTA), Theracal LC, TheraCal PT - Pulpitis - Irreversible
Not applicableCompletedCukurova University722024-12-162026-06-25
A Comparative Analysis of Biomaterials for Retrograde Filling in Apical Surgery.
Mineral Trioxide Aggregate, BioCeramic Root Repair Material Fast Set Putty. - Periapical Lesion
Not applicableCompletedUniversity of Valencia1102024-02-082026-07-13
Premixed Bioceramic Putty as an Apical Plug in Immature Anterior Permanent Teeth
Mineral trioxide aggregate, Premixed Bioceramic Putty - Periapical Periodontitis
Not applicableCompletedTanta University502023-11-222025-04-18
Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis
Epigallocatechin gallate (EGCG), Sodium hypochlorite (NaOCl), Mineral trioxide aggregate (MTA) - Irreversible Pulpitis
Not applicableCompletedCairo University642023-07-012026-08-24
Comparative Evaluation of Melatonin Versus MTA on Vital Pulp Therapy in Young Permanent First Molars: An in Vivo Study
Mineral trioxide aggregate (dressing material), Melatonin (dressing material) - Dental Caries in Children, Vital Pulp Therapy
Not applicableUnknownSuez Canal University452023-05-202024-08-02
Simvastatin Versus MTA in Pulpotomy of Immature Permanent Molars
Simvastatin - Pulp Exposure, Dental
Early Phase 1UnknownAhmad Elheeny1282023-04-012023-05-26
Evaluation of Conservative Management of Teeth With Deep Cavitated Carious Lesions
RetroMTA, TheraCal, Fuji IX - Deep Caries, Pulp Exposure, Dental
Phase 2 / Phase 3UnknownCairo University902023-01-012023-12-15
Clinical And Radiographic Evaluation Of Nano-Propolis, Nano-Curcumin and MTA as Direct Pulp Capping Agents in Young Permanant Teeth
MTA Cement, propolis nano particle, curcumin nanoparticles - Traumatic Pulp Exposure in Children
Phase 1CompletedAl-Azhar University542022-12-202025-07-11
Clinical and Histological Evaluation of Hesperidin as a Direct Pulp Capping Material
Hesperidin, Mineral Trioxide Aggregate (MTA) - Pulp Exposure, Dental, Dental Pulp Capping
Not applicableCompletedCairo University322022-09-012024-05-07
Comparing Two Indirect Pulp Capping Agents for Permanent Teeth
Silver diamine fluoride, Mineral trioxide aggregate - Deep Caries
Not applicableUnknownCairo University302022-08-012022-06-21
Survival Rate After TheraCal PT Pulpotomy Versus MTA Pulpotomy in Children With Vital Primary Molars.
MTA, TheraCal PT - Reversible Pulpitis
Not applicableUnknownCairo University202022-03-012022-03-04
Evaluation of Apexogenesis With Human Treated Dentin Matrix in Young Permanent Molars
human treated dentin matrix, Mineral Trioxide Aggregate - Dentin Bridge
Phase 1 / Phase 2Completednora mostafa mohammed abo shanady202022-01-182024-07-30
Pulpotomy Materials in Primary Molars
Mineral Trioxide Aggregate (MTA), Biodentine, Ferric Sulfate - Dental Caries, Pulpitis
Not applicableCompletedSacide Duman222022-01-012025-08-13
Direct Pulp Capping in Primary Molars
Mineral trioxide aggregate (MTA), Hard setting Calcium Hydroxide (Dycal) - Direct Pulp Capping
Phase 3CompletedMansoura University522022-01-012023-09-26

Showing 20 of 51. Sign in to see all of them.

Conditions studied

Dental Pulp Exposure (9)  ·  Dental Pulp Necrosis (5)  ·  Pulpitis (5)  ·  Dental Caries (4)  ·  Dental Pulp Diseases (4)  ·  Periapical Periodontitis (4)  ·  Stomatognathic Diseases (2)  ·  Tooth Diseases (2)  ·  Alveolar Bone Loss (1)  ·  Molar Hypomineralization (1)  ·  Mouth Diseases (1)  ·  Necrosis (1)  ·  Periapical Diseases (1)  ·  Signs and Symptoms (1)  ·  Tooth Injuries (1)

Sponsors

Cairo University (9)  ·  Al-Azhar University (2)  ·  Gihan M Abuelniel ,PhD (2)  ·  Jordan University of Science and Technology (2)  ·  Mansoura University (2)  ·  Ahmad Elheeny (1)  ·  Ain Shams University (1)  ·  All India Institute of Medical Sciences (1)  ·  Altamash Institute of Dental Medicine (1)  ·  Altinbas University (1)  ·  Amany hasanean Abd El sadek (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Azad University of Medical Sciences (1)  ·  Cukurova University (1)  ·  Ege University (1)

Countries

Egypt (17)  ·  Turkey (Türkiye) (5)  ·  United States (4)  ·  Iran (3)  ·  India (2)  ·  Jordan (2)  ·  Pakistan (2)  ·  Brazil (1)  ·  Chile (1)  ·  China (1)  ·  Denmark (1)  ·  France (1)  ·  Poland (1)  ·  Saudi Arabia (1)  ·  Spain (1)

Top investigators

Lama Awawdeh, PhD (2)  ·  A Y El Hosainy, PhD (1)  ·  Afnan M Saber, MSc (1)  ·  Alicja Nowicka, DDS, PhD (1)  ·  Ann Wenzel, professor (1)  ·  C C Youngson (1)  ·  Claudia Brizuela (1)  ·  Dina Abdelwahab, M.Sc. (1)  ·  Domenico Ricucci, MD, DDS (1)  ·  Gayatri Malik, DMD (1)  ·  Ghada AH Elbaz, Professor (1)  ·  Gihan M Abuelniel (1)

Results publications

PMID 11585142, PMID 16536148, PMID 16805357, PMID 17256303, PMID 18565375, PMID 21752247, PMID 22838228, PMID 23550521, PMID 23690353, PMID 24959601, PMID 25467231, PMID 25872627, PMID 27175451, PMID 27377108, PMID 28206897, PMID 28692829, PMID 28836288, PMID 29070150, PMID 30864114, PMID 31321573, PMID 32041360, PMID 33440268, PMID 3481571, PMID 38281619, PMID 41353690, PMID 6957533

NIH funding

U01DE016750 (1)